What is BCTX's current stock price?

BCTX (BriaCell Therapeutics Corp.) is currently trading at $3.49 with a market cap of $6.6M.

What sector is BriaCell Therapeutics Corp. in?

BriaCell Therapeutics Corp. (BCTX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

BCTX BriaCell Therapeutics Corp.

Healthcare

$3.49-6.18%ClosedMarket Cap: $6.6M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.32

P/S

0.00

EV/EBITDA

0.76

DCF Value

$4.27

FCF Yield

-466.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-166.3%

ROA

-88.2%

ROIC

-100.9%

Financials

View All

Period	Revenue	Net Income	EPS
Q2 null	$0.00	$-7.4M	$—
Q1 null	$0.00	$-11.5M	$—
Q4 null	$0.00	$-11.1M	$—
FY null	$0.00	$-36.5M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2025-08-27

Trading Activity

Insider Trades

View All

Lustig Marcdirector, 10 percent owner:

BuyMon May 20

Williams William V.officer: President, CEO

BuyWed Dec 28

Bondarenko Jamiesonofficer: Chairman

BuyWed Dec 28

Bondarenko Jamiesondirector

BuyTue Dec 20

Bondarenko Jamiesondirector

SellThu Aug 11

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

1.63

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Peers